NASDAQ: XTLBXtl Biopharmaceuticals Ltd Stock Ownership - Who owns Xtl Biopharmaceuticals?
Insider buying vs selling
Have Xtl Biopharmaceuticals Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when XTLB insiders and whales buy or sell their stock.
XTLB Shareholders
What type of owners hold Xtl Biopharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph Edelman | 12.83% | 113,123,680 | $152.72M | Insider |
| Noked Israel Ltd | 0.02% | 198,888 | $268.50k | Institution |
| Benzion Weiner | 0.01% | 50,000 | $67.50k | Insider |
| Michael S. Weiss | 0.00% | 25,000 | $33.75k | Insider |
| Ron Bentsur | 0.00% | 20,101 | $27.14k | Insider |
| Rhumbline Advisers | 0.00% | 17,261 | $23.30k | Institution |
| Morgan Stanley | 0.00% | 11,011 | $14.86k | Institution |
| William Kessler | 0.00% | 5,000 | $6.75k | Insider |
| Ubs Group Ag | 0.00% | 1,336 | $1.80k | Institution |
| Concourse Financial Group Securities Inc | 0.00% | 0 | $0.00 | Institution |
XTLB vs Biotech Stocks
Xtl Biopharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.